Arch Therapeutics, Inc. financial statements, including revenue, expenses, profit, and loss

The total revenue of ARTH for the last quarter is 45.87 k USD, and it's 16.07% higher compared to the previous quarter. The net income of Q1 24 is -2.68 M USD.